vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）とNATURES SUNSHINE PRODUCTS INC（NATR）の財務データ比較。上の社名をクリックして会社を切り替えられます
NATURES SUNSHINE PRODUCTS INCの直近四半期売上が大きい（$123.8M vs $104.1M、GRID DYNAMICS HOLDINGS, INC.の約1.2倍）。NATURES SUNSHINE PRODUCTS INCの純利益率が高く（3.3% vs -1.4%、差は4.7%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs 3.7%）。過去8四半期でGRID DYNAMICS HOLDINGS, INC.の売上複合成長率が高い（12.0% vs 5.6%）
Escape Dynamics Inc.はコロラド州に本拠を置くテクノロジー企業で、2010年から2015年にかけて事業を展開し、単段軌道投入可能で電磁駆動の再利用可能なスペースプレーンの市場投入を目指し開発を行っていました。
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
GDYN vs NATR — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $104.1M | $123.8M |
| 純利益 | $-1.5M | $4.1M |
| 粗利率 | 34.8% | 72.5% |
| 営業利益率 | 61.7% | 4.3% |
| 純利益率 | -1.4% | 3.3% |
| 売上前年比 | 3.7% | 4.7% |
| 純利益前年比 | -150.6% | 1379.4% |
| EPS（希薄化後） | $-0.02 | $0.23 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $104.1M | — | ||
| Q4 25 | $106.2M | $123.8M | ||
| Q3 25 | $104.2M | $128.3M | ||
| Q2 25 | $101.1M | $114.8M | ||
| Q1 25 | $100.4M | $113.2M | ||
| Q4 24 | $100.3M | $118.2M | ||
| Q3 24 | $87.4M | $114.6M | ||
| Q2 24 | $83.0M | $110.6M |
| Q1 26 | $-1.5M | — | ||
| Q4 25 | $306.0K | $4.1M | ||
| Q3 25 | $1.2M | $5.3M | ||
| Q2 25 | $5.3M | $5.3M | ||
| Q1 25 | $2.9M | $4.7M | ||
| Q4 24 | $4.5M | $-321.0K | ||
| Q3 24 | $4.3M | $4.3M | ||
| Q2 24 | $-817.0K | $1.3M |
| Q1 26 | 34.8% | — | ||
| Q4 25 | 34.0% | 72.5% | ||
| Q3 25 | 33.3% | 73.3% | ||
| Q2 25 | 34.1% | 71.7% | ||
| Q1 25 | 36.8% | 72.1% | ||
| Q4 24 | 36.9% | 72.0% | ||
| Q3 24 | 37.4% | 71.3% | ||
| Q2 24 | 35.6% | 71.4% |
| Q1 26 | 61.7% | — | ||
| Q4 25 | 0.5% | 4.3% | ||
| Q3 25 | -0.2% | 7.0% | ||
| Q2 25 | -0.1% | 3.7% | ||
| Q1 25 | -2.0% | 5.4% | ||
| Q4 24 | 1.3% | 3.8% | ||
| Q3 24 | 2.4% | 4.6% | ||
| Q2 24 | 0.0% | 5.1% |
| Q1 26 | -1.4% | — | ||
| Q4 25 | 0.3% | 3.3% | ||
| Q3 25 | 1.1% | 4.2% | ||
| Q2 25 | 5.2% | 4.6% | ||
| Q1 25 | 2.9% | 4.2% | ||
| Q4 24 | 4.5% | -0.3% | ||
| Q3 24 | 4.9% | 3.8% | ||
| Q2 24 | -1.0% | 1.2% |
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.01 | $0.23 | ||
| Q3 25 | $0.01 | $0.30 | ||
| Q2 25 | $0.06 | $0.28 | ||
| Q1 25 | $0.03 | $0.25 | ||
| Q4 24 | $0.06 | $-0.02 | ||
| Q3 24 | $0.05 | $0.23 | ||
| Q2 24 | $-0.01 | $0.07 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $327.5M | $93.9M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $530.1M | $161.6M |
| 総資産 | $605.0M | $261.1M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $327.5M | — | ||
| Q4 25 | $342.1M | $93.9M | ||
| Q3 25 | $338.6M | $95.6M | ||
| Q2 25 | $336.8M | $81.3M | ||
| Q1 25 | $325.5M | $86.5M | ||
| Q4 24 | $334.7M | $84.7M | ||
| Q3 24 | $231.3M | $78.7M | ||
| Q2 24 | $256.0M | $68.7M |
| Q1 26 | $530.1M | — | ||
| Q4 25 | $542.1M | $161.6M | ||
| Q3 25 | $537.7M | $166.7M | ||
| Q2 25 | $532.2M | $163.7M | ||
| Q1 25 | $517.4M | $167.1M | ||
| Q4 24 | $517.8M | $161.0M | ||
| Q3 24 | $400.2M | $162.6M | ||
| Q2 24 | $388.4M | $156.4M |
| Q1 26 | $605.0M | — | ||
| Q4 25 | $612.9M | $261.1M | ||
| Q3 25 | $613.2M | $264.8M | ||
| Q2 25 | $608.9M | $254.9M | ||
| Q1 25 | $590.9M | $252.7M | ||
| Q4 24 | $592.2M | $240.9M | ||
| Q3 24 | $477.3M | $245.3M | ||
| Q2 24 | $443.6M | $235.8M |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | — | $9.9M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $7.6M |
| FCFマージンFCF / 売上 | — | 6.1% |
| 設備投資強度設備投資 / 売上 | — | 1.9% |
| キャッシュ転換率営業CF / 純利益 | — | 2.41× |
| 直近12ヶ月FCF直近4四半期 | — | $28.8M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $9.9M | ||
| Q3 25 | $7.0M | $18.5M | ||
| Q2 25 | $14.4M | $4.3M | ||
| Q1 25 | $9.4M | $2.6M | ||
| Q4 24 | $7.1M | $12.2M | ||
| Q3 24 | $9.2M | $9.6M | ||
| Q2 24 | $10.7M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | $7.6M | ||
| Q3 25 | $2.9M | $16.8M | ||
| Q2 25 | $10.2M | $3.0M | ||
| Q1 25 | $6.0M | $1.5M | ||
| Q4 24 | $4.4M | $10.0M | ||
| Q3 24 | $5.9M | $7.9M | ||
| Q2 24 | $8.0M | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | 6.1% | ||
| Q3 25 | 2.8% | 13.1% | ||
| Q2 25 | 10.1% | 2.6% | ||
| Q1 25 | 6.0% | 1.3% | ||
| Q4 24 | 4.4% | 8.5% | ||
| Q3 24 | 6.8% | 6.9% | ||
| Q2 24 | 9.7% | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 1.9% | ||
| Q3 25 | 3.9% | 1.3% | ||
| Q2 25 | 4.1% | 1.2% | ||
| Q1 25 | 3.3% | 1.0% | ||
| Q4 24 | 2.6% | 1.9% | ||
| Q3 24 | 3.7% | 1.5% | ||
| Q2 24 | 3.2% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 32.34× | 2.41× | ||
| Q3 25 | 5.92× | 3.46× | ||
| Q2 25 | 2.73× | 0.81× | ||
| Q1 25 | 3.21× | 0.55× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | 2.21× | ||
| Q2 24 | — | 0.97× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
GDYN
セグメントデータなし
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
